AD
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Curevo Vaccine
Chemicals & Related Products · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18911 North Creek Pkwy Ste 150, Bothell,...Phone Number
(206) 492-5722Website
www.curevovaccine.comRevenue
$10.6 MillionIndustry
About Curevo Vaccine
Curevo Vaccine is a clinical-stage biotech company focused on developing next-generation non-mRNA, adjuvanted subunit vaccines for unmet medical needs. Their lead product, amezosvatein, targets shingles and chickenpox and has shown promising results in clinical trials, aiming to improve vaccine tolerability and accessibility. By concentrating on one medical need at a time, they strive to bring more effective and better-tolerated vaccines to market quickly. The company aims to address issues such as vaccine hesitancy and accessibility, particularly for immunocompromised patients.Explore more
Curevo Vaccine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Curevo Vaccine
Compare insights from companies similar to Curevo Vaccine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.7M
11-50
Private
-
1994
SS
Steven SpiegelCEO Emeritus and Board Member and Chair Long Range Planning Committee
<$5M
11-50
Private
$50.4M
1982
RS
Richard ShermanVice President, Business Development & Director & General Counsel
Curevo Vaccine Tech Stack
A closer look at the technologies used by Curevo Vaccine
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curevo Vaccine
Sign Up For FreeTo access detailed company insights
Curevo Vaccine is a clinical-stage biotech company focused on developing next-generation non-mRNA, adjuvanted subunit vaccines for unmet medical needs. Their lead product, amezosvatein, targets shingles and chickenpox and has shown promising results in clinical trials, aiming to improve vaccine tolerability and accessibility. By concentrating on on... Read More
